Nuo Therapeutics, Inc. (AURX)

Market Cap	65.56M
Revenue (ttm)	1.61M
Net Income (ttm)	-2.36M
Shares Out	46.83M
EPS (ttm)	-0.05
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	113,150
Average Volume	16,512
Open	1.400
Previous Close	1.450
Day's Range	1.383 - 1.400
52-Week Range	0.252 - 1.930
Beta	-972.97
RSI	42.93
Earnings Date	Aug 11, 2025

About Nuo Therapeutics

Nuo Therapeutics, Inc. operates as a regenerative therapies company that develops, commercializes, and markets cell-based technologies that harness the regenerative capacity of the human body to trigger natural healing in the United States. The company offers the Aurix System, which separates autologous blood to produce a platelet-based therapy for the chronic wound care market. It serves hospital outpatient wound care clinics and other private practice physicians treating chronic wounds. The company was formerly known as Cytomedix, Inc. and ch...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1998
• Employees: 9
• Stock Exchange: OTCMKTS
• Ticker Symbol: AURX

Financial Performance

In 2024, Nuo Therapeutics's revenue was $1.37 million, an increase of 124.34% compared to the previous year's $608,525. Losses were -$2.32 million, -26.73% less than in 2023.